CVE:SQD SQI Diagnostics (SQD) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free SQD Stock Alerts C$0.02 0.00 (0.00%) (As of 06/14/2023) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.18Volume65,000 shsAverage Volume172,133 shsMarket CapitalizationC$6.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisEarningsInsider TradesStock AnalysisEarningsInsider Trades Get SQI Diagnostics alerts: Email Address Ad Weiss RatingsThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW. About SQI Diagnostics Stock (CVE:SQD)SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. The company also offers TOR-dx, a lung test, which enables the surgeon to assess the health of the donor's lung; and a COVID-19 at-home antibody test kit; the RALI-Dx, a COVID-19 severity triage lab test; and RALI-fast, a COVID-19 severity triage POC test. In addition, it offers microarray tests for protein and antibody testing workflow. The company was founded in 1999 and is headquartered in Toronto, Canada.Read More SQD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SQD Stock News HeadlinesMarch 28, 2024 | seekingalpha.comBVAXF BioVaxys Technology Corp.June 16, 2023 | finance.yahoo.comSQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy FilingJune 6, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - SQDMay 18, 2023 | finance.yahoo.comThis SQI Diagnostics Insider Increased Their Holding In The Last YearMay 17, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Friday (SQD)April 29, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc up on Friday (SQD)April 27, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc up on Wednesday (SQD)April 25, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Monday (SQD)April 21, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Thursday (SQD)April 15, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc down on Friday (SQD)April 12, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Wednesday (SQD)April 11, 2023 | theglobeandmail.comClosing Bell: Sqi Diagnostics Inc flat on Tuesday (SQD)March 20, 2023 | finance.yahoo.comSQI DIAGNOSTICS ANNOUNCES ISSUANCE OF PREVIOUSLY ANNOUNCED BONUS WARRANTSFebruary 6, 2023 | ca.finance.yahoo.comSQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND DEFERRAL OF CERTAIN INTEREST PAYMENTSDecember 9, 2022 | finance.yahoo.comThe Independent Director of SQI Diagnostics Inc. (CVE:SQD), Gerald Connor, Just Bought 5.8% More SharesOctober 19, 2022 | finance.yahoo.comSQI DIAGNOSTICS EXTENDS MATURITY DATE OF PIVOT CREDIT FACILITY AND ANNOUNCES DEFERRAL OF CERTAIN INTEREST PAYMENTSSeptember 19, 2022 | theglobeandmail.comSQI Diagnostics: Top 10 Undervalued Medical Diagnostics & Research Industry Sector Stocks on TSX Venture Exchange (SQD)August 30, 2022 | seekingalpha.comSQI Diagnostics reports Q3 resultsMarch 3, 2022 | finance.yahoo.comNew York State Approves SQI Diagnostics' EXACT COVID-19 Antibody AssayFebruary 9, 2022 | finance.yahoo.comSQI DIAGNOSTICS PROVIDES UPDATE ON PREVIOUSLY ANNOUNCED ASSET PURCHASE TRANSACTION WITH PBI DIAGNOSTICSJanuary 31, 2022 | ca.finance.yahoo.comStocks in play: SQI Diagnostics IncNovember 6, 2021 | yahoo.comWilmot Matthews Is The Non-Independent Director of SQI Diagnostics Inc. (CVE:SQD) And They Just Picked Up 8.1% More SharesAugust 18, 2021 | markets.businessinsider.comSQI Diagnostics Reports Third Quarter 2021 ResultsJuly 23, 2021 | stockhouse.comFDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 PatientsSee More Headlines Receive SQD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SQI Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/21/2024Next Earnings (Estimated)6/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolCVE:SQD CUSIPN/A CIKN/A Websqidiagnostics.com Phone+1-416-6749500FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-19,140,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-74.70% Debt Debt-to-Equity Ratio464.33 Current Ratio0.12 Quick Ratio0.40 Sales & Book Value Annual SalesC$3.04 million Price / Sales2.01 Cash FlowC$0.00 per share Price / Cash Flow8.50 Book ValueC($0.04) per share Price / Book-0.38Miscellaneous Outstanding Shares407,170,000Free FloatN/AMarket CapC$6.11 million OptionableNot Optionable Beta-0.21 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Andrew Morris (Age 58)Advisor to the Board & CEO Comp: $543.04kMr. Morlan Reddock C.F.A.CPA, CGA, M.B.A., CFO & VP of AdministrationDr. Eric Brouwer Ph.D. (Age 55)Chief Scientific Officer & Advisor to the Board Comp: $350kDr. Peter Lea Ph.D. (Age 79)Founder Mr. Tim McGoughChief Commercial OfficerKey Competitors3D SignaturesCVE:DXDLexaGeneCVE:LXGLED Medical DiagnosticsCVE:LMDTitan MedicalTSE:TMDHarvest One CannabisCVE:HVTView All Competitors SQD Stock Analysis - Frequently Asked Questions How have SQD shares performed in 2024? SQI Diagnostics' stock was trading at C$0.02 at the beginning of the year. Since then, SQD shares have increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. When is SQI Diagnostics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, June 4th 2024. View our SQD earnings forecast. What other stocks do shareholders of SQI Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other SQI Diagnostics investors own include The Cigna Group (CI), Global Payments (GPN), Alarm.com (ALRM), Baxter International (BAX), Becton, Dickinson and Company (BDX), Charter Communications (CHTR), Costco Wholesale (COST), Canadian Tire (CTC.A) and LadRx (CYTR). How do I buy shares of SQI Diagnostics? Shares of SQD stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:SQD) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldNext President (Not Trump. Not Biden.)The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQI Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.